Route of administration other than oral for concomitant me­di­cation [Bioanalytics]

posted by qualityassurance – Jordan, 2020-02-04 10:28 (187 d 21:41 ago) – Posting: # 21141
Views: 1,652

Hello all,

We have given concomitant medication to subjects during clinical phase and the route of administration was topical, local (eye drops), IV, IM.

Can anyone suggest me :confused::confused: if it is required to include these medications in concomitant medication experiment if the route of administration is other than oral (e.g. IV, topical, eye drops) during clinical phase?

Complete thread:

Activity
 Admin contact
20,991 posts in 4,375 threads, 1,460 registered users;
online 15 (0 registered, 15 guests [including 11 identified bots]).
Forum time: Monday 08:09 UTC (Europe/Vienna)

[Those] who have an excessive faith in their theories or in their
ideas are not only poorly disposed to make discoveries, but they
also make very poor observations.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5